Second wave anti-HCV protease inhibitors: too little too late?

被引：2

作者：

De Nicola, Stella ^{[1
,2
]}

Aghemo, Alessio ^{[1
,2
]}

机构：

[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Hepatol, Milan, Italy

[2] Univ Milan, Milan, Italy

来源：

LIVER INTERNATIONAL | 2014年 / 34卷 / 07期

关键词：

FALDAPREVIR; BOCEPREVIR; TELAPREVIR; RITONAVIR; THERAPY;

D O I：

10.1111/liv.12543

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：E168 / E170

页数：3

共 14 条

[1] New Horizons in Hepatitis C Antiviral Therapy With Direct-Acting Antivirals [J].

Aghemo, Alessio ;

De Francesco, Raffaele .

HEPATOLOGY, 2013, 58 (01) :428-438

[2] Directly acting antivirals for the treatment of chronic hepatitis C: Unresolved topics from registration trials [J].

Aghemo, Alessio ;

Degasperi, Elisabetta ;

Colombo, Massimo .

DIGESTIVE AND LIVER DISEASE, 2013, 45 (01) :1-7

[3] Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir [J].

Asselah, Tarik ;

Marcellin, Patrick .

LIVER INTERNATIONAL, 2014, 34 :60-68

[4] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[5] New therapeutic strategies in HCV: second-generation protease inhibitors [J].

Clark, Virginia C. ;

Peter, Joy A. ;

Nelson, David R. .

LIVER INTERNATIONAL, 2013, 33 :80-84

[6] DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4 [J].

Everson, Gregory ;

Cooper, Curtis ;

Hezode, Christophe ;

Shiffman, Mitchell L. ;

Yoshida, Eric ;

Beltran-Jaramillo, Teresita ;

Andreone, Pietro ;

Bruno, Savino ;

Ferenci, Peter ;

Zeuzem, Stefan ;

Brunda, Michael ;

Le Pogam, Sophie ;

Najera, Isabel ;

Zhou, Julian ;

Navarro, Mercidita T. ;

Voulgari, Athina ;

Shulman, Nancy S. ;

Yetzer, Ellen S. .

LIVER INTERNATIONAL, 2015, 35 (01) :108-119

[7] Induction effects of ritonavir: Implications for drug interactions [J].

Foisy, Michelle M. ;

Yakiwchuk, Erin M. ;

Hughes, Christine A. .

ANNALS OF PHARMACOTHERAPY, 2008, 42 (7-8) :1048-1059

[8] Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial [J].

Gane, Edward J. ;

Roberts, Stuart K. ;

Stedman, Catherine A. M. ;

Angus, Peter W. ;

Ritchie, Brett ;

Elston, Rob ;

Ipe, David ;

Morcos, Peter N. ;

Baher, Linda ;

Najera, Isabel ;

Chu, Tom ;

Lopatin, Uri ;

Berrey, M. Michelle ;

Bradford, William ;

Laughlin, Mark ;

Shulman, Nancy S. ;

Smith, Patrick F. .

LANCET, 2010, 376 (9751) :1467-1475

[9] Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection [J].

Jacobson, Ira M. ;

McHutchison, John G. ;

Dusheiko, Geoffrey ;

Di Bisceglie, Adrian M. ;

Reddy, K. Rajender ;

Bzowej, Natalie H. ;

Marcellin, Patrick ;

Muir, Andrew J. ;

Ferenci, Peter ;

Flisiak, Robert ;

George, Jacob ;

Rizzetto, Mario ;

Shouval, Daniel ;

Sola, Ricard ;

Terg, Ruben A. ;

Yoshida, Eric M. ;

Adda, Nathalie ;

Bengtsson, Leif ;

Sankoh, Abdul J. ;

Kieffer, Tara L. ;

George, Shelley ;

Kauffman, Robert S. ;

Zeuzem, Stefan .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) :2405-2416

[10]

LAWITZ E, 2013, 20 C RETR OPP INF AT

← 1 2 →